TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Jun 9, 4:07 PM ET

Lichtenstein Chen 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Jun 9, 2025

Insider Transaction Report

Form 4
Period: 2025-06-05
Transactions
  • Award

    Restricted Share Units

    2025-06-05+14,49214,492 total
    Ordinary Shares (14,492 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4